Neuropediatrics 2004; 35(5): 297-301
DOI: 10.1055/s-2004-821172
Short Communication

Georg Thieme Verlag KG Stuttgart · New York

Late Infantile Onset Krabbe Disease in Siblings with Cortical Degeneration and Absence of Cerebral Globoid Cells

M. R. Del Bigio1 , A. E. Chudley2 , F. A. Booth2 , S. Pacin3
  • 1Department of Pathology, University of Manitoba, Health Sciences Centre, and Manitoba Institute for Child Health, Winnipeg, Canada
  • 2Department of Pediatrics, University of Manitoba, Health Sciences Centre, and Manitoba Institute for Child Health, Winnipeg, Canada
  • 3Department of Medicine, University of Manitoba, Health Sciences Centre, and Manitoba Institute for Child Health, Winnipeg, Canada
Further Information

Publication History

Received: July 14, 2003

Accepted after Revision: March 2, 2004

Publication Date:
10 August 2004 (online)

Abstract

Krabbe disease, a disorder caused by the deficiency of lysosomal galactosylceramidase, is typically associated with cerebral white matter degeneration, cortical sparing, accumulation of macrophages (“globoid cells”), and ultrastructural needle-shaped inclusions. Two sisters presented with progressive neurological deterioration beginning before the age of 2.5 years. The first, who died at the age of 9 years, exhibited profound destruction of cerebral white matter with sparing of subcortical fibers but no globoid cells. The brain of the second, who died at the age of 15 years and who had a proven galactosylceramidase deficiency, exhibited white matter destruction, previously undescribed circumscribed spongiform cortical degeneration (postcentral, inferior temporal, cingulate), and cerebellar atrophy, but no globoid cells. The peripheral nerve biopsies from both girls exhibited typical needle-shaped inclusions in Schwann cells. These observations confirm the rare reports that Krabbe disease is not always associated with globoid cells in the brain. Psychosine, which accumulates in the brain, might be toxic to cortical neurons following prolonged survival. The reason for the regional susceptibility in the cerebral cortex is unknown.

References

  • 1 Brockmann K, Dechent P, Wilken B, Rusch O, Frahm J. et al . Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease.  Neurology. 2003;  60 819-825
  • 2 Cho K H, Kim M W, Kim S U. Tissue culture model of Krabbe's disease: psychosine cytotoxicity in rat oligodendrocyte culture.  Dev Neurosci. 1997;  19 321-327
  • 3 Dunn H G, Dolman C L, Farrell D F, Tischler B, Hasinoff C. et al . Krabbe's leukodystrophy without globoid cells.  Neurology. 1976;  26 1035-1041
  • 4 Giri S, Jatana M, Rattan R, Won J S, Singh I. et al . Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease.  Faseb J. 2002;  16 661-672
  • 5 Gullotta F, Pavone L, Mollica F, Grasso S, Valenti C. Krabbe's disease with unusual clinical and morphological features.  Neuropaediatrie. 1979;  10 395-400
  • 6 Haq E, Giri S, Singh I, Singh A K. Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line.  J Neurochem. 2003;  86 1428-1440
  • 7 Hirato J, Nakazato Y, Sasaki A, Hikima A, Shimizu S. et al . Krabbe's disease with giant lamellar bodies in Purkinje cells.  Acta Neuropathol (Berl). 1994;  88 78-84
  • 8 Ida H, Eto Y. Biochemical and morphological studies of dorsal root ganglion and its cultured cells from twitcher mouse (murine globoid cell leukodystrophy).  Brain Dev. 1990;  12 412-416
  • 9 Ida H, Eto Y, Maekawa K. Biochemical pathogenesis of demyelination in globoid cell leukodystrophy (Krabbe's disease): the effects of psychosine upon oligodendroglial cell culture.  Acta Paediatr Jpn. 1990;  32 20-26
  • 10 Itoh M, Hayashi M, Fujioka Y, Nagashima K, Morimatsu Y. et al . Immunohistological study of globoid cell leukodystrophy.  Brain Dev. 2002;  24 284-290
  • 11 Jatana M, Giri S, Singh A K. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine.  Neurosci Lett. 2002;  330 183-187
  • 12 Kreda S M, Fujita N, Suzuki K. Expression of sphingolipid activator protein gene in brain and systemic organs of developing mice.  Dev Neurosci. 1994;  16 90-99
  • 13 Luzi P, Rafi M A, Wenger D A. Structure and organization of the human galactocerebrosidase (GALC) gene.  Genomics. 1995;  26 407-409
  • 14 McKelvie P, Vine P, Hopkins I, Poulos A. A case of Krabbe's leukodystrophy without globoid cells.  Pathology. 1990;  22 235-238
  • 15 Mitsuo K, Kobayashi T, Shinnoh N, Goto I. Biosynthesis of galactosylsphingosine (psychosine) in the twitcher mouse.  Neurochem Res. 1989;  14 899-903
  • 16 Robinson N, Cumings J N. Biochemical and histochemical observations on Krabbe's disease. (Globoid body diffuse sclerosis).  Acta Neuropathol. 1967;  9 280-289
  • 17 Schlaepfer W W, Prensky A L. Quantitative and qualitative study of sural nerve biopsies in Krabbe's disease.  Acta Neuropathol. 1972;  20 55-66
  • 18 Sugama S, Kim S U, Ida H, Eto Y. Psychosine cytotoxicity in rat neural cell cultures and protection by phorbol ester and dimethyl sulfoxide.  Pediatr Res. 1990;  28 473-476
  • 19 Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update.  J Child Neurol. 2003;  18 595-603
  • 20 Suzuki K. Twenty five years of the “psychosine hypothesis”: a personal perspective of its history and present status.  Neurochem Res. 1998;  23 251-259
  • 21 Taniike M, Mohri I, Eguchi N, Beuckmann C T, Suzuki K. et al . Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model.  J Neurosci. 2002;  22 4885-4896
  • 22 Tapasi S, Padma P, Setty O H. Effect of psychosine on mitochondrial function.  Indian J Biochem Biophys. 1998;  35 161-165
  • 23 Wenger D A. Krabbe disease (globoid cell leukodystrophy). Rosenberg RN, Prusiner SB, DiMauro S et al The Molecular and Genetic Basis of Neurological Disease. 2nd ed. Boston; Butterworth-Heinemann 1997: 421-431
  • 24 Wenger D A, Rafi M A, Luzi P, Datto J, Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy.  Mol Genet Metab. 2000;  70 1-9
  • 25 Wenger D A, Suzuki K, Suzuki Y, Suzuki K. Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). Scriver CR, Beaudet AL, Sly WS et al The Metabolic & Molecular Bases of Inherited Disease. Vol. 3. New York; McGraw-Hill 2001: 3669-3694
  • 26 Williams R S, Ferrante R J, Caviness Jr V S. The isolated human cortex. A Golgi analysis of Krabbe's disease.  Arch Neurol. 1979;  36 134-139
  • 27 Yunis E J, Lee R E. The ultrastructure of globoid (Krabbe) leukodystrophy.  Lab Invest. 1969;  21 415-419
  • 28 Zarifi M K, Tzika A A, Astrakas L G, Poussaint T Y, Anthony D C. et al . Magnetic resonance spectroscopy and magnetic resonance imaging findings in Krabbe's disease.  J Child Neurol. 2001;  16 522-526

M. D., PhD, FRCPC Marc R. Del Bigio

Canada Research Chair in Developmental Neuropathology
Department of Pathology
University of Manitoba

770 Bannatyne Avenue

Winnipeg, MB R3E 0W3

Canada

Email: delbigi@cc.umanitoba.ca

    >